Published in Invest Ophthalmol Vis Sci on July 01, 2012
Drug and gene delivery to the back of the eye: from bench to bedside. Invest Ophthalmol Vis Sci (2014) 0.93
Particle-stabilized emulsion droplets for gravity-mediated targeting in the posterior segment of the eye. Adv Healthc Mater (2014) 0.92
Ocular delivery of macromolecules. J Control Release (2014) 0.91
Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma. J Control Release (2016) 0.88
Targeted delivery of antiglaucoma drugs to the supraciliary space using microneedles. Invest Ophthalmol Vis Sci (2014) 0.87
Formulation to target delivery to the ciliary body and choroid via the suprachoroidal space of the eye using microneedles. Eur J Pharm Biopharm (2015) 0.85
Implantable MicroPump for Drug Delivery in Patients with Diabetic Macular Edema. Transl Vis Sci Technol (2014) 0.82
Circumferential flow of particles in the suprachoroidal space is impeded by the posterior ciliary arteries. Exp Eye Res (2016) 0.81
Single compartment drug delivery. J Control Release (2014) 0.79
Distribution of particles, small molecules and polymeric formulation excipients in the suprachoroidal space after microneedle injection. Exp Eye Res (2016) 0.79
Exciting directions in glaucoma. Can J Ophthalmol (2014) 0.78
In vivo high-frequency contrast-enhanced ultrasonography of choroidal melanoma in rabbits: imaging features and histopathologic correlations. Br J Ophthalmol (2013) 0.78
Nanomedicine in the application of uveal melanoma. Int J Ophthalmol (2016) 0.77
Intrastromal delivery of bevacizumab using microneedles to treat corneal neovascularization. Invest Ophthalmol Vis Sci (2014) 0.77
Thickness and Closure Kinetics of the Suprachoroidal Space Following Microneedle Injection of Liquid Formulations. Invest Ophthalmol Vis Sci (2017) 0.76
Clearance Kinetics and Clearance Routes of Molecules From the Suprachoroidal Space After Microneedle Injection. Invest Ophthalmol Vis Sci (2017) 0.76
The suprachoroidal space: from potential space to a space with potential. Clin Ophthalmol (2016) 0.76
Suprachoroidal injection of ketorolac tromethamine does not cause retinal damage. Neural Regen Res (2012) 0.75
Advances in drug delivery to the posterior segment. Curr Opin Ophthalmol (2015) 0.75
Transdermal Delivery of Functional Collagen Via Polyvinylpyrrolidone Microneedles. Ann Biomed Eng (2015) 0.75
The HIF-1 antagonist acriflavine: visualization in retina and suppression of ocular neovascularization. J Mol Med (Berl) (2016) 0.75
Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol (2004) 18.86
Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. Arch Ophthalmol (2008) 2.14
Ciliochoroidal detachment. Surv Ophthalmol (1983) 1.62
Ocular drug delivery. Expert Opin Drug Deliv (2006) 1.61
Intravitreal injection of therapeutic agents. Retina (2009) 1.53
The safety profile of long-term, high-dose intraocular corticosteroid delivery. Am J Ophthalmol (2005) 1.51
Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci (2000) 1.43
Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment. Am J Ophthalmol (2006) 1.41
Neovascular age-related macular degeneration: potential therapies. Drugs (2008) 1.38
Complications of intravitreal injection of triamcinolone acetonide. Can J Ophthalmol (2005) 1.33
Steroid-induced iatrogenic glaucoma. Ophthalmic Res (2011) 1.27
Suprachoroidal drug delivery to the back of the eye using hollow microneedles. Pharm Res (2010) 1.20
Biodegradable implants for sustained drug release in the eye. Pharm Res (2010) 1.20
Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye. Invest Ophthalmol Vis Sci (2002) 1.13
Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model. Invest Ophthalmol Vis Sci (2011) 1.12
Intrascleral drug delivery to the eye using hollow microneedles. Pharm Res (2008) 1.07
Physiology of the choroidal vascular bed. Int Ophthalmol (1983) 1.05
Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging. Invest Ophthalmol Vis Sci (2007) 1.02
Biodegradable intraocular therapies for retinal disorders: progress to date. Drugs Aging (2010) 1.00
A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis. Invest Ophthalmol Vis Sci (2006) 0.98
Experimental ciliochoroidal detachment. Effect on intraocular pressure and aqueous humor flow. Arch Ophthalmol (1979) 0.85
Medical devices for the treatment of eye diseases. Handb Exp Pharmacol (2010) 0.84
In vivo and in vitro study of suprachoroidal fibrin glue. Jpn J Ophthalmol (2009) 0.83
Dissolving polymer microneedle patches for influenza vaccination. Nat Med (2010) 3.24
Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci U S A (2003) 2.82
Coated microneedles for transdermal delivery. J Control Release (2006) 2.66
Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev (2012) 2.65
Effect of microneedle design on pain in human volunteers. Clin J Pain (2008) 2.48
Dissolving microneedles for transdermal drug delivery. Biomaterials (2008) 2.47
Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Release (2005) 2.19
Transdermal delivery of insulin using microneedles in vivo. Pharm Res (2004) 2.07
Mechanism of intracellular delivery by acoustic cavitation. Ultrasound Med Biol (2006) 2.02
Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. J Biomech (2004) 1.91
Interface fluid syndrome in human eye bank corneas after LASIK: causes and pathogenesis. Ophthalmology (2007) 1.89
Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge. Proc Natl Acad Sci U S A (2009) 1.82
Micro-scale devices for transdermal drug delivery. Int J Pharm (2008) 1.81
Increased endothelial cell density in the paracentral and peripheral regions of the human cornea. Am J Ophthalmol (2003) 1.79
Transdermal influenza immunization with vaccine-coated microneedle arrays. PLoS One (2009) 1.78
Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Proc Natl Acad Sci U S A (2008) 1.77
Polymer microneedles for controlled-release drug delivery. Pharm Res (2006) 1.72
Review of corneal endothelial specular microscopy for FDA clinical trials of refractive procedures, surgical devices, and new intraocular drugs and solutions. Cornea (2008) 1.68
Coating formulations for microneedles. Pharm Res (2007) 1.63
Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. J Control Release (2009) 1.62
Ocular drug delivery. Expert Opin Drug Deliv (2006) 1.61
Depth-dependent cohesive tensile strength in human donor corneas: implications for refractive surgery. J Refract Surg (2008) 1.58
Toxic anterior segment syndrome. J Cataract Refract Surg (2006) 1.53
Precise microinjection into skin using hollow microneedles. J Invest Dermatol (2006) 1.51
Minimally invasive protein delivery with rapidly dissolving polymer microneedles. Adv Mater (2008) 1.49
Mechanism of fluid infusion during microneedle insertion and retraction. J Control Release (2006) 1.46
Measurement and correlation of acoustic cavitation with cellular bioeffects. Ultrasound Med Biol (2006) 1.43
Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin. PLoS One (2009) 1.42
Mechanisms of corneal tissue cross-linking in response to treatment with topical riboflavin and long-wavelength ultraviolet radiation (UVA). Invest Ophthalmol Vis Sci (2009) 1.41
Evaluation of endothelial mucin layer thickness after phacoemulsification with next generation ophthalmic irrigating solution. Cornea (2008) 1.39
Physical parameters influencing optimization of ultrasound-mediated DNA transfection. Ultrasound Med Biol (2004) 1.37
Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles. J Infect Dis (2010) 1.36
Delivery of molecules into cells using carbon nanoparticles activated by femtosecond laser pulses. Nat Nanotechnol (2010) 1.36
Hollow metal microneedles for insulin delivery to diabetic rats. IEEE Trans Biomed Eng (2005) 1.35
Cohesive tensile strength of human LASIK wounds with histologic, ultrastructural, and clinical correlations. J Refract Surg (2005) 1.33
Tapered conical polymer microneedles fabricated using an integrated lens technique for transdermal drug delivery. IEEE Trans Biomed Eng (2007) 1.30
Corneal ectasia after excimer laser keratorefractive surgery: histopathology, ultrastructure, and pathophysiology. Ophthalmology (2008) 1.22
Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization. J Virol (2010) 1.22
Kinetics of skin resealing after insertion of microneedles in human subjects. J Control Release (2011) 1.21
Suprachoroidal drug delivery to the back of the eye using hollow microneedles. Pharm Res (2010) 1.20
Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles. Diabetes Technol Ther (2009) 1.19
Bioeffects caused by changes in acoustic cavitation bubble density and cell concentration: a unified explanation based on cell-to-bubble ratio and blast radius. Ultrasound Med Biol (2003) 1.19
Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization. Proc Natl Acad Sci U S A (2009) 1.18
Histologic, ultrastructural, and immunofluorescent evaluation of human laser-assisted in situ keratomileusis corneal wounds. Arch Ophthalmol (2005) 1.18
Biomechanical and wound healing characteristics of corneas after excimer laser keratorefractive surgery: is there a difference between advanced surface ablation and sub-Bowman's keratomileusis? J Refract Surg (2008) 1.17
Dissolving microneedle patch for transdermal delivery of human growth hormone. Small (2011) 1.17
Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIa. J Drug Target (2008) 1.17
Minimally invasive extraction of dermal interstitial fluid for glucose monitoring using microneedles. Diabetes Technol Ther (2005) 1.17
Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma. Ophthalmology (2005) 1.16
Improved influenza vaccination in the skin using vaccine coated microneedles. Vaccine (2009) 1.16
Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration. Mol Vis (2008) 1.15
Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection. Sci Rep (2012) 1.14
Microinfusion using hollow microneedles. Pharm Res (2006) 1.13
Fabrication of dissolving polymer microneedles for controlled drug encapsulation and delivery: Bubble and pedestal microneedle designs. J Pharm Sci (2010) 1.13
Quantification of optison bubble size and lifetime during sonication dominant role of secondary cavitation bubbles causing acoustic bioeffects. J Acoust Soc Am (2004) 1.12
Evidence suggesting the existence of stem cells for the human corneal endothelium. Mol Vis (2005) 1.12
The effect of heat on skin permeability. Int J Pharm (2008) 1.11
An electrically active microneedle array for electroporation. Biomed Microdevices (2010) 1.10
Stem cell markers in the human posterior limbus and corneal endothelium of unwounded and wounded corneas. Mol Vis (2007) 1.10
Transdermal delivery of naltrexol and skin permeability lifetime after microneedle treatment in hairless guinea pigs. J Pharm Sci (2010) 1.09
Long-term histopathologic findings in human corneal wounds after refractive surgical procedures. Am J Ophthalmol (2005) 1.08
A microneedle roller for transdermal drug delivery. Eur J Pharm Biopharm (2010) 1.08
Intrascleral drug delivery to the eye using hollow microneedles. Pharm Res (2008) 1.07
Multistate outbreak of toxic anterior segment syndrome, 2005. J Cataract Refract Surg (2008) 1.06
Antibody blockade of junctional adhesion molecule-A in rabbit corneal endothelial tight junctions produces corneal swelling. Invest Ophthalmol Vis Sci (2006) 1.06
Does needle size matter? J Diabetes Sci Technol (2007) 1.05
Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles. J Control Release (2010) 1.05
Retinal function after subconjunctival injection of carboplatin in fibrin sealant. Retina (2004) 1.05
Enzymatic detergents and toxic anterior segment syndrome. Ophthalmology (2013) 1.05
Rapid pharmacokinetics of intradermal insulin administered using microneedles in type 1 diabetes subjects. Diabetes Technol Ther (2011) 1.05
Separable arrowhead microneedles. J Control Release (2010) 1.05
Pharmacokinetics of intraocular drug delivery by periocular injections using ocular fluorophotometry. Invest Ophthalmol Vis Sci (2007) 1.05
Shear-induced intracellular loading of cells with molecules by controlled microfluidics. Biotechnol Bioeng (2008) 1.04
Coated microneedles for drug delivery to the eye. Invest Ophthalmol Vis Sci (2007) 1.04
Stability of influenza vaccine coated onto microneedles. Biomaterials (2012) 1.04
Stability kinetics of influenza vaccine coated onto microneedles during drying and storage. Pharm Res (2010) 1.03
Layer-by-layer assembly of DNA- and protein-containing films on microneedles for drug delivery to the skin. Biomacromolecules (2010) 1.03
Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles. Antiviral Res (2010) 1.03
Measles vaccination using a microneedle patch. Vaccine (2012) 1.03
Local response to microneedle-based influenza immunization in the skin. MBio (2012) 1.03
Future directions for therapeutic ultrasound. Ultrasound Med Biol (2007) 1.03
Transdermal delivery enhanced by magainin pore-forming peptide. J Control Release (2007) 1.02
Equilibrium loading of cells with macromolecules by ultrasound: effects of molecular size and acoustic energy. J Pharm Sci (2002) 1.02
Effect of mitomycin C on the corneal endothelium when used for corneal subepithelial haze prophylaxis following photorefractive keratectomy. J Refract Surg (2007) 1.01
Flux across [corrected] microneedle-treated skin is increased by increasing charge of naltrexone and naltrexol in vitro. Pharm Res (2008) 1.01
Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice. Clin Vaccine Immunol (2010) 1.01
Serological memory and long-term protection to novel H1N1 influenza virus after skin vaccination. J Infect Dis (2011) 1.01
Influence of dosage form on the intravitreal pharmacokinetics of diclofenac. Invest Ophthalmol Vis Sci (2009) 1.00
Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch. Vaccine (2012) 1.00
Retracted Sclera-choroid-RPE transport of eight β-blockers in human, bovine, porcine, rabbit, and rat models. Invest Ophthalmol Vis Sci (2011) 1.00